VANESSA NGUYEN: Open Payments
NPI 1205468691 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 47 payments from 15 companies in 2025. Trend: 2023 $1,040 · 2024 $1,101 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Amgen Inc. | 13 | $177 |
| Novo Nordisk Inc | 5 | $75 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| ABBVIE INC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Abbott Laboratories | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $29 |
Products named: AIRSUPRA, OTEZLA, ROTATEQ, Rybelsus, VRAYLAR, Kerendia, EVENITY, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
